Revance Therapeutics, Inc. (Nasdaq: RVNC) filed a registration with the U.S. Securities and Exchange Commission for an Initial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE